Acute Porphyria Drug Database

Monograph

N04BC05 - Pramipexole
Propably not porphyrinogenic
PNP

Rationale
Mainly excreted in unchanged form.
Chemical description
Dopamine agonist used to improve motoric function in Parkinson´s disease. More than 90 % excreted in unchanged form by the kidneys. No data pointing to CYP-interaction.
IPNet drug reports
Uneventful use reported in 1 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes N04B / N04BC or go back.
Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Glepark · Mirapexin · Oprymea · Pramipexol · Sifrol Mirapexin · Oprymea · Pramipexol · Pramipexole · Sifrol Mirapexin · Oprymea · Pramipexol Mirapexin · Oprymea · Pramiperal · Pramipexolo Mirapexin · Oprymea · Pramipexol Mirapexin · Neliprax · Oprymea · Pipexus · Pramipexole · Sifrol Glepark · Mariprax · Mirapexin · Oprymea · Pramipexol · Pramipexole · Sifrol Oprymea · Pramipexole · Sifrol Mirapexin · Oprymea · Pramipexole · Sifrol Mirapexin · Oprymea · Pramipexol · Pramipexole · Sifrol Mirapexin · Oprymea · Pramipexol · Pramipexole · Sifrol Mirapexin · Oprymea · Pramipexol · Pramipexole · Sifrol Medopexol · Mirapexin · Oprymea · Pramipexole · Sifrol Mirapexin · Oprymea
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙